Table 3. Univariate and multivariate analysis of prognostic factors for overall survival in 70 male patients after living donor liver transplantation.
| Factors | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|
| HR (95% CI) | P | HR (95% CI) | P | ||
| Recipient age | 1.05 (0.99–1.11) | 0.096 | 1.04 (0.99–1.10) | 0.132 | |
| BMI >25 kg/m2 | 0.37 (0.09–1.61) | 0.187 | – | – | |
| Progressive hyperbilirubinemia | 1.46 (0.53–4.03) | 0.467 | – | – | |
| Refractory ascites | 2.23 (0.81–6.13) | 0.122 | – | – | |
| History of varicose veins bleeding | 1.32 (0.18–9.87) | 0.787 | – | – | |
| MELD score >20 | 1.38 (0.50–3.79) | 0.539 | – | – | |
| Child-Pugh classification C | 1.41 (0.60–3.36) | 0.434 | – | – | |
| Portal vein thrombosis | 2.52 (0.84–7.56) | 0.099 | 7.33 (0.84–64.3) | 0.072 | |
| Pretransplant infection | 1.51 (0.35–6.51) | 0.580 | – | – | |
| Sarcopenia | 3.04 (1.11–8.36) | 0.031 | 2.94 (1.04–8.30) | 0.042 | |
| Pre-transplant hospital stay | 2.67 (1.09–6.54) | 0.032 | 2.46 (1.00–6.05) | 0.049 | |
| Operative time >10 hours | 0.87 (0.37–2.06) | 0.750 | – | – | |
| Donor BMI, kg/m2 | 0.93 (0.79–1.09) | 0.374 | – | – | |
| GRWR >0.8% | 0.61 (0.21–1.82) | 0.378 | – | – | |
| ABO incompatible | 1.40 (0.54–3.62) | 0.490 | – | – | |
| Biologically related donor | 1.02 (0.30–3.47) | 0.974 | – | – | |
HR, hazard ratio; CI, confidence interval; BMI, body mass index; MELD, model for end-stage liver disease score; GRWR, graft-to-recipient weight ratio; HR, hazard ratio.